New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.

about

Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells.

P2860

Q40545036-B625C2DA-7A6B-4A31-9541-BF077450CB4B Q47131939-3474337E-02B6-4F8C-9C96-6D0E5F8A6F48

P2860

New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.

Item

http://www.wikidata.org/entity/Q41454895

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

New amino acid changes in drug ...... hepatitis B virus genotype H.

@en

type

Item

label

New amino acid changes in drug ...... hepatitis B virus genotype H.

@en

prefLabel

New amino acid changes in drug ...... hepatitis B virus genotype H.

@en

P1476

New amino acid changes in drug ...... hepatitis B virus genotype H.

@en

P2093

D A Fernández-Galindo

http://www.w3.org/2001/XMLSchema#string

F Sánchez-Ávila

http://www.w3.org/2001/XMLSchema#string

J Armendáriz-Borunda

http://www.w3.org/2001/XMLSchema#string

L V Sánchez-Orozco

http://www.w3.org/2001/XMLSchema#string

M Bueno-Topete

http://www.w3.org/2001/XMLSchema#string

P Gómez-Quiróz

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B virus taxonomy and hepatitis B virus genotypes

A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J

The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis

Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.

Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.

Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.

Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

P304

985-992

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24098

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

L Bobadilla-Morales

P577

2015-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25732900

http://www.w3.org/2001/XMLSchema#string

New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.

about

P2860

P2860

New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698